Infinity Pharmaceuticals Inc.

NASDAQ:INFI 4:00:00 PM EDT

0.64

0.00 (+0.13%)

6:33:24 PM EDT: $0.66 +0.02 (+3.40%)

Market Cap (Intraday)	56.90M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$8.05 Million
Adjusted EPS	-$0.03

See more estimates

10-Day MA	$0.64
50-Day MA	$0.58
200-Day MA	$0.86

See more pivots

Infinity Pharmaceuticals Inc. Stock, NASDAQ:INFI

1100 Massachusetts Avenue, 4th floor, Cambridge, Massachusetts 02138

United States of America

Phone: +1.617.453.1000

Number of Employees: 33

http://www.infi.com

Description

Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development segment. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.